Your shopping cart is empty!
Tenvir-EM restricts the growth of HIV-1 reverse transcriptase, an enzyme required for growth of HIV-1 virus in the human body. It reduces the level of HIV-1 in the blood simultaneously increasing T cells, which further stimulate the immune response to help the body fight infection. Reduction in HIV-1 virus levels in the blood lowers the chances of infections or death due to opportunistic infections. It is also known as HIV-1 nucleoside analog reverse transcriptase inhibitor (NRTI). It contains a combination of Emtricitabine and tenofovir disoproxil fumarate. It is to be used along with other anti-HIV-1 medicines to treat patients between the age of 18 - 65 years. Tenvir-EM does not lower your risk of transmitting HIV-1 virus to other people.
(0 reviews)
